$XENE 8-K/A SEC Filings

Filed On	Filing
17 Oct 2025	8-K/A: Departure/Election of Directors or Officers; Compensation; Other Events We are pleased to offer you a position with Xenon Pharmaceuticals USA Inc. (the “Company”), a wholly-owned subsidiary of Xenon Pharmaceuticals Inc. (the “Parent” and, together with the Company, “Xenon”), as Chief Financial Officer, comme...
14 Jan 2021	8-K/A: Departure/Election of Directors or Officers; Compensation

Comments